Growth Metrics

Idexx Laboratories (IDXX) Other Accumulated Expenses (2016 - 2018)

Idexx Laboratories has reported Other Accumulated Expenses over the past 9 years, most recently at $65.8 million for Q1 2018.

  • For Q1 2018, Other Accumulated Expenses rose 18.53% year-over-year to $65.8 million; the TTM value through Mar 2018 reached $65.8 million, up 18.53%, while the annual FY2017 figure was $64.4 million, 10.49% down from the prior year.
  • Other Accumulated Expenses for Q1 2018 was $65.8 million at Idexx Laboratories, up from $64.4 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $72.0 million in Q4 2016 and troughed at $44.6 million in Q1 2014.
  • A 5-year average of $58.9 million and a median of $60.2 million in 2015 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: surged 38.03% in 2015 and later fell 11.34% in 2017.
  • Year by year, Other Accumulated Expenses stood at $55.7 million in 2014, then increased by 17.99% to $65.7 million in 2015, then grew by 9.62% to $72.0 million in 2016, then fell by 10.49% to $64.4 million in 2017, then grew by 2.18% to $65.8 million in 2018.
  • Business Quant data shows Other Accumulated Expenses for IDXX at $65.8 million in Q1 2018, $64.4 million in Q4 2017, and $60.8 million in Q3 2017.